Several δ-opioid receptor ligands display no subtype selectivity to the human δ-opioid receptor

European Journal of Pharmacology

Volumn 451, Issue 3, 2002, Pages 257-264

  Parkhill, Amy L ^a   Bidlack, Jean M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Opioid receptor; 35S GTP S; Binding; Chinese hamster ovary (CHO) cell; Naltrindole derivative; Subtype

Indexed keywords

7 BENZYLIDENENALTREXONE; DELTA OPIATE RECEPTOR; DELTORPHIN; DELTORPHIN II; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); ISOTHIOCYANIC ACID DERIVATIVE; LIGAND; MU OPIATE RECEPTOR; NALTRIBEN; NALTRINDOLE; NALTRINDOLE 5' ISOTHIOCYANATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; BINDING AFFINITY; BINDING SITE; CHO CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; IC 50; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; BINDING SITES; CELL MEMBRANE; CHO CELLS; CRICETINAE; DRUG INTERACTIONS; HUMANS; RECEPTORS, OPIOID, DELTA; TRANSFECTION;

EID: 0037144154     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02241-0     Document Type: Article

References (33)

1. Allouche S., Hasbi A., Ferey V., Sola B., Jauzac P., Polastron J. Pharmacological δ1- and δ2-opioid receptor subtypes in the human neuroblastoma cell line SK-N-BE: no evidence for distinct molecular entities. Biochem. Pharmacol. 59:2000;915-925.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Buzas B., Izenwasser S., Portoghese P., Cox B.M. Evidence for delta opioid receptor subtypes regulating adenylyl cyclase in rat brain. Life Sci. 54:1994;101-106.
4. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
5. 6 glioma cell line stably expressing the delta opioid receptor. J. Pharmacol. Exp. Ther. 283:1997;501-510.
6. Connor M.A., Keir M.J., Henderson G. δ-Opioid receptor mobilization of intracellular calcium in SH-SY5Y cells: lack of evidence of δ-receptor subtypes. Neuropharmacology. 36:1997;125-133.
7. Cvejic S., Devi L.A. Dimerization of the δ opioid receptor: implication for a role in receptor internalization. J. Biol. Chem. 272:1997;26959-26964.
8. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., O'Dowd B.F. Oligomerization of μ- and δ-opioid receptors: generation of novel functional properties. J. Biol. Chem. 275:2000;26128-26135.
9. Gomes I., Jordan B.A., Gupta A., Trapaidze N., Nagy V., Devi L.A. Heterodimerization of μ and δ opioid receptors: a role in opiate synergy. J. Neurosci. 20(RC110):2000;1-5.
10. Hammond D.L., Stewart P.E., Littell L. Antinociception and δ-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone. J. Pharmacol. Exp. Ther. 274:1995;1317-1324.
11. 6]enkephalin and 5′-naltrindole isothiocyanate (5′-NTII): evidence for δ receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;1069-1075.
12. Kim K.-W., Kim S.-J., Shin B.-S., Choi H.-Y. Ligand binding profiles of δ-opioid receptor in human cerebral cortex membranes: evidence of δ-opioid receptor heterogeneity. Life Sci. 68:2001;1649-1656.
13. Law S., Resine T. Changes in the association of G protein subunits with the cloned mouse δ opioid receptor on agonist stimulation. J. Pharmacol. Exp. Ther. 281:1997;1476-1486.
14. 1 subtype. Life Sci. 58:1996;PL331-PL336.
15. 2]deltorphin II in mice: evidence for delta receptor sub-types. J. Pharmacol. Exp. Ther. 258:1991;583-587.
16. Negri L., Potenza R.L., Corsi R., Melchiorri P. Evidence of two subtypes of δ opioid receptors in rat brain. Eur. J. Pharmacol. 196:1991;335-336.
17. Portoghese P.S., Sultana M., Nagase H., Takemori A.E. Application of the message-address concept in the design of highly potent and selective non-peptide δ opioid receptor antagonists. J. Med. Chem. 31:1988;281-282.
18. Portoghese P.S., Sultana M., Takemori A.E. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur. J. Pharmacol. 146:1988;185-186.
19. Portoghese P.S., Nagase H., MaloneyHuss K.E., Lin C.-E., Takemori A.E. Role of spacer and address components in peptidomimetic δ opioid receptor antagonists related to naltrindole. J. Med. Chem. 34:1991;1715-1720.
20. 1-opioid receptor antagonist: 7-benzylidenenaltrexone. Eur. J. Pharmacol. 218:1992;195-196.
21. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., Reisine T. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:1994;330-334.
22. Rossi G.C., Su W., Leventhal L., Su H., Pasternak G.W. Antisense mapping DOR-1 in mice: further support for δ receptor subtypes. Brain Res. 753:1997;176-179.
23. Sanchez-Blazquez P., Garzon J. Delta opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. J. Pharmacol. Exp. Ther. 285:1998;820-827.
24. Simon E.J., Hiller J.M. Opioid peptides and opioid receptors. Siegal G.J.et al. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 5th ed. 1994;321-339 Raven Press, New York, NY.
25. Simonin F., Befort K., Gaveriaux-Ruff C., Matthes H., Nappey V., Lannes B., Micheletti G., Kieffer B. The human δ-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain. Mol. Pharmacol. 46:1994;1015-1021.
26. Sofuoglu M., Portoghese P.S., Takemori A.E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;676-680.
27. Sofuoglu M., Portoghese P.S., Takemori A.E. δ-Opioid receptor binding in mouse brain: evidence for heterogenous binding sites. Eur. J. Pharmacol. 216:1992;273-277.
28. 1 opioid receptor antagonist in the mouse spinal cord. Life Sci. 52:1993;769-775.
29. 35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects. J. Pharmacol. Exp. Ther. 283:1997;1276-1284.
30. 2]deltorphin I and II analogues; in vitro blood brain barrier permeability and stability. J. Pharmacol. Exp. Ther. 281:1997;817-825.
31. Toll L., Polgar W.E., Auh J.S. Characterization of the δ-opioid receptor found in SH-SY5Y neuroblastoma cells. Eur. J. Pharmacol. 323:1997;261-267.
32. Traynor J.R., Elliot J. δ-Opioid receptor subtypes and cross-talk with μ-receptors. Trends Pharmacol. Sci. 14:1993;84-86.
33. Zaki P.A., Bilsky E.J., Vanderah T.W., Lai J., Evans C.J., Porreca F. Opioid receptor types and subtypes: the δ receptor as a model. Annu. Rev. Pharmacol. Toxicol. 36:1996;379-401.